Karin Lovgren-Bengtsson
Overview
Explore the profile of Karin Lovgren-Bengtsson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
153
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Venkatraman N, Tiono A, Bowyer G, Bellamy D, Stockdale L, Powlson J, et al.
Lancet Microbe
. 2025 Jan;
6(3):100868.
PMID: 39805302
Background: Malaria remains a substantial public health burden among young children in sub-Saharan Africa and a highly efficacious vaccine eliciting a durable immune response would be a useful tool for...
2.
Cuevas-Romero J, Cerriteno-Sanchez J, Lara-Romero R, Vega-Lopez M, Ramirez-Estudillo C, Ramirez-Mendoza H, et al.
J Vet Med Sci
. 2022 Oct;
84(12):1595-1604.
PMID: 36273875
Porcine rubulavirus (PRV) is a contagious virus that affects the Mexican swine industry. This work aimed to evaluate the immunogenicity of an recombinant hemagglutinin neuraminidase-Porcine rubulavirus (rHN-PorPV) candidate vaccine on...
3.
Venkatraman N, Anagnostou N, Bliss C, Bowyer G, Wright D, Lovgren-Bengtsson K, et al.
Vaccine
. 2017 Sep;
35(45):6208-6217.
PMID: 28941620
The use of viral vectors in heterologous prime-boost regimens to induce potent T cell responses in addition to humoral immunity is a promising vaccination strategy in the fight against malaria....
4.
Reimer J, Karlsson K, Lovgren-Bengtsson K, Magnusson S, Fuentes A, Stertman L
PLoS One
. 2012 Jul;
7(7):e41451.
PMID: 22844480
Saponin-based adjuvants are widely used to enhance humoral and cellular immune responses towards vaccine antigens, although it is not yet completely known how they mediate their stimulatory effects. The aim...
5.
Azevedo M, Gonzalez A, Yuan L, Jeong K, Iosef C, Nguyen T, et al.
Clin Vaccine Immunol
. 2010 Jan;
17(3):420-8.
PMID: 20107005
We determined the impact of mucosal prime/boost regimens and vaccine type (attenuated Wa human rotavirus [AttHRV] or nonreplicating Wa 2/6 rotavirus-like particles [VLP]) on protection and antibody-secreting cell (ASC) responses...
6.
Pinitkiatisakul S, Friedman M, Wikman M, Mattsson J, Lovgren-Bengtsson K, Stahl S, et al.
Vaccine
. 2007 Feb;
25(18):3658-68.
PMID: 17280751
Recombinant NcSRS2, a major immunodominant surface antigen of the intracellular protozoan parasite Neospora caninum, was used as a model antigen to compare the immunogenicity of iscoms prepared according to three...
7.
Pahar B, Cantu M, Zhao W, Kuroda M, Veazey R, Montefiori D, et al.
Vaccine
. 2006 Oct;
24(47-48):6839-49.
PMID: 17050045
The difficulty in developing an effective vaccine to contain the HIV/AIDS epidemic coupled with the fact that primary HIV-1 infection typically occurs via mucosal sites has increased emphasis on vaccine...
8.
Wikman M, Friedman M, Pinitkiatisakul S, Andersson C, Lovgren-Bengtsson K, Lunden A, et al.
Expert Rev Vaccines
. 2006 Jul;
5(3):395-403.
PMID: 16827623
In recent years, several studies have been reported with the common aim of generating general expression systems for straightforward production and subsequent coupling of expressed antigens to an adjuvant system....
9.
Nguyen T, Yuan L, Azevedo M, Jeong K, Gonzalez A, Iosef C, et al.
Clin Vaccine Immunol
. 2006 Apr;
13(4):475-85.
PMID: 16603615
We investigated maternal antibody (MatAb) effects on protection and immune responses to rotavirus vaccines. Gnotobiotic pigs were injected intraperitoneally at birth with pooled serum from sows hyperimmunized with human rotavirus...
10.
Nguyen T, Yuan L, Azevedo M, Jeong K, Gonzalez A, Iosef C, et al.
Vaccine
. 2005 Dec;
24(13):2302-16.
PMID: 16361002
We investigated effects of low titer (Lo) circulating MatAb on protection and immunogenicity of attenuated (Att) human rotavirus (HRV) priming and 2/6-virus-like particle (VLP)-immunostimulating complex (ISCOM) boosting (AttHRV/VLP) or VLP-ISCOM...